Table-II.

Genotype distribution of ten SNPs in NER and HRR pathways between cases and controls.

Gene	Genotype	Cases	%	Controls	%	OR(95%CI)1	P value
ERCC1 rs11615	TT	63	42.57	135	45.3	1.0(Ref.)	-
	TC+CC	85	57.43	163	54.7	1.12(0.74-1.70)	0.58
ERCC1 rs3212986	GG	79	53.38	169	56.71	1.0(Ref.)	-
	GA+AA	69	46.62	129	43.29	1.14(0.75-1.73)	0.5
ERCC2 rs1799793	GG	84	56.76	201	67.45	1.0(Ref.)	-
	GA+AA	64	43.24	97	32.55	1.58(1.03-2.41)	0.03
ERCC2 rs13181	AA	86	58.11	181	60.74	1.0(Ref.)	-
	AC+CC	62	41.89	117	39.26	1.12(0.73-1.70)	0.59
NBN rs709816	GG	55	37.16	115	38.59	1.0(Ref.)	-
	GC+CC	93	62.84	183	61.41	1.06(0.69-1.63)	0.78
NBN rs1805794	GG	52	35.14	127	42.62	1.0(Ref.)	-
	GC+CC	96	64.86	171	57.38	2.66(1.73-4.08)	<0.001
RAD51 rs1801320	GG	101	68.24	213	71.48	1.0(Ref.)	-
	GC+CC	47	31.76	85	28.52	1.17(0.74-1.82)	0.48
RAD51 rs1801321	GG	88	59.46	187	62.75	1.0(Ref.)	-
	GT+TT	60	40.54	111	37.25	1.15(0.75-1.75)	0.5
RAD51 rs12593359	TT	49	33.11	105	35.23	1.0(Ref.)	-
	TG+GG	99	66.89	193	64.77	1.10(0.71-1.71)	0.66
XRCC3 rs861539	CC	77	52.03	173	58.05	1.0(Ref.)	-
	CT+TT	71	47.97	125	41.95	1.28(0.84-1.93)	0.23

¹Adjusted for sex, age and family history of cancer.